The Lancet

The Lancet

@thelancet.com

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823. 🌐 thelancet.com

22.8K followers56 following1K posts

Pinned

The way digital technologies are built & governed creates real health risks worldwide. In a new issue, a Series links digital media use to mental health & sleep problems plus reduced physical activity. Authors call for urgent, coordinated action. Read this & more: spkl.io/633217kyih

Early-onset colorectal cancer (EO-CRC) is increasing globally. In The Lancet Regional Health - Eastern Mediterranean, authors assessed the burden, temporal trends, and future projections of EO-CRC across the WHO Eastern Mediterranean Region: spkl.io/633287kJDY

Use of an AI chatbot ahead of GP appointments required no safety interventions in first real-world small study. However, authors caution that this study doesn't suggest AI chatbots are able to diagnose or triage patients without a doctor's oversight. spkl.io/633267kySA

📣 Extended deadline: Nov 6 Still time to present your research: Submit abstracts on women’s cancers, haematological cancers, or cancer imaging to the #LancetSummit and help shape the future of #CancerControl in China and beyond: spkl.io/633297XLAb

Presented today at #MSToronto2026: The REMODEL-1 and REMODEL-2 studies find that remibrutinib was superior to teriflunomide in patients with relapsing multiple sclerosis, while maintaining a favourable safety profile. Explore the research: spkl.io/633297kz4D

The way digital technologies are built & governed creates real health risks worldwide. In a new issue, a Series links digital media use to mental health & sleep problems plus reduced physical activity. Authors call for urgent, coordinated action. Read this & more: spkl.io/633217kyih

By 2050, almost 1 billion people are expected to live with osteoarthritis—a disabling musculoskeletal condition with currently no cure. A new Health Policy outlines a roadmap for global health policy to prioritise, provide care, and prevent osteoarthritis: spkl.io/633207XBra

ICYMI—New antibody treatment reduces number of new abnormal bone lesions by at least 90% in people with ultra-rare genetic disorder, fibrodysplasia ossificans progressiva (FOP), phase 3 study shows. Read now: spkl.io/633227X6ri

TRIUMPH-2 findings suggest that retatrutide might advance the treatment of people with obesity and type 2 diabetes, showing bodyweight reduction alongside improvements in glycaemic control and cardiometabolic risk factors. Read more: spkl.io/633207VNIE #EASD2026

The Lancet reposted

What will shape the health of the next generation? The Lancet Commission on 21st Century Threats to Health identified 17 catastrophic threats, drawing on expertise from health, economics, security, governance, and technology. @thelancet.com Read more: ms.spr.ly/63321aqvhJ

View full thread

“The Commission expands, quantifies, and legitimises a far broader range of interconnected dangers to humanity.” Read a linked Editorial - 'Rethinking threats to human survival' tinyurl.com/ymhh7wdm

🧠 Migraine is a chronic neurological disorder that affects over 1 billion people globally each year, with women predominantly affected. A new Seminar discusses typical symptoms, mechanisms, and treatment options: spkl.io/633257VNQH

The 17 catastrophic threats–from climate change to antimicrobial resistance to malicious use of AI–are interconnected. The Commission doesn’t offer a fixed policy ranking but provides decision-makers with a common framework for coordinated action.

Use of an AI chatbot ahead of GP appointments required no safety interventions in first real-world small study. However, authors caution that this study doesn't suggest AI chatbots are able to diagnose or triage patients without a doctor's oversight. spkl.io/633297VfkR

Ahead of #WorldMentalHealthDay, our Editorial highlights the value of lived experience in mental health research and services, alongside critical challenges in its implementation. Read now: spkl.io/633257VNub

🆕 Out now: The Lancet Regional Health – Eastern Mediterranean’s inaugural issue. #goldopenaccess “The scale of the challenges the region has faced this past year can be hard to absorb. It is in this context that this journal takes shape.” Explore the new issue: spkl.io/633277VQx7

The Lancet reposted

Can we delay the progression of type 1 diabetes? Join Chantal Mathieu at The #LancetSummit (Nov 30-Dec 2, Sitges) to explore the latest advances in #T1D. Register by Oct 31, 2026 using voucher code TLDC100 to save €100: spkl.io/633257VXhZ

Peripheral arterial disease (PAD) affects more than 300 million people worldwide—yet it remains under-recognised, underdiagnosed, and undertreated. A new Editorial discusses a Lancet Series aiming to address this major health burden: spkl.io/633207pL2I

In our latest issue, a study evaluates whether wealth redistribution policies can mitigate the health impact of the current official development assistance (ODA) defunding crisis. Read the study & explore the full issue: spkl.io/633257p2T3

🧵 GLP-1 receptor agonists (RA) are transforming diabetes and obesity. Women are the predominant users, but uptake has outpaced guidance. 2 papers in @lancetobgyn-wh.bsky.social explore GLP-1RA treatment in women: access, safety, & equity. #EASD2026 tinyurl.com/4h3852em

tinyurl.comGLP-1 Receptor Agonists in Women's HealthGlucagon-like peptide-1 (GLP-1) receptor agonists are transforming the management of obesity and metabolic disease, with important implications across women’s health.

The Lancet reposted

🌏Less than 5 days to go! Join @thelancet.com & DTH-Lab on 5 October for Unsafe by design? launching the new Lancet Series on the digital determinants of health. 📅 5 October 2026 | 13:00–14:30 BST / 14:00–15:30 CEST / Register now: scan qr / https://tr.ee/iY3uhd

New antibody treatment reduces number of new abnormal bone lesions by at least 90% in people with ultra-rare genetic disorder, fibrodysplasia ossificans progressiva (FOP), phase 3 study shows. Read now: spkl.io/633297T2st

The Lancet reposted

Early-onset colorectal cancer (EO-CRC) is increasing globally. In The Lancet Regional Health - Eastern Mediterranean, authors assessed the burden, temporal trends, and future projections of EO-CRC across the WHO Eastern Mediterranean Region: spkl.io/633217TcwT